{"id":34250,"date":"2025-12-20T20:31:34","date_gmt":"2025-12-20T19:31:34","guid":{"rendered":"https:\/\/tirzepatyd.eu\/?post_type=product&p=34250"},"modified":"2026-06-19T17:06:42","modified_gmt":"2026-06-19T15:06:42","slug":"orforglipron","status":"publish","type":"product","link":"https:\/\/tirzepatyd.eu\/en\/shop-product\/orforglipron\/","title":{"rendered":"Orforglipron (Oral GLP-1) 5 mg 60 caps"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Orforglipron 5 mg \u2013 Characteristics of the Investigational Drug<\/h2>

Orforglipron 5 mg<\/strong> It is a synthetic, non-peptide GLP-1 receptor (GLP-1R) agonist, classified as a new-generation small-molecule investigational compound being studied in research projects related to metabolism, energy balance, and incretin signaling. In the scientific literature, it is referred to as LY3502970 and is described as one of the most advanced non-peptide GLP-1 receptor ligands.<\/p>

Unlike classic GLP-1 analogs based on a peptide structure, orforglipron is a small-molecule compound with the molecular formula C\u2084\u2088H\u2084\u2088F\u2082N\u2081\u2080O\u2085, a molecular weight of 882.96 g\/mol, and CAS number 2212020-52-3. Its properties make it a valuable reference material in research on GLP-1R receptor activation and the analysis of molecular mechanisms involved in the regulation of energy homeostasis.<\/p>

See also: GLP-1 in a vial\u00a0<\/a><\/p>

Orforglipron in Metabolism Research<\/h3>

In recent years, orforglipron 5 mg has been the subject of numerous scientific publications focusing on GLP-1 receptor biology. Researchers are analyzing its effect on signaling pathways involved in the regulation of glucose metabolism, energy balance, and the mechanisms responsible for controlling the body\u2019s energy intake.<\/p>

Scientific interest in this compound stems, among other things, from its non-peptide structure and its ability to activate the GLP-1R receptor while exhibiting pharmacological properties that differ from those of classic peptide analogs. As a result, orforglipron 5 mg is often used as a model compound in comparative analyses and research projects involving new generations of GLP-1 agonists.<\/p>

\u00a0<\/p>

\"Orforglipron<\/a><\/strong><\/p>

\u00a0<\/p>

\u00a0<\/p>

Sources:<\/p>

https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2302392<\/a><\/p>

https:\/\/pubmed.ncbi.nlm.nih.gov\/37369232\/<\/a><\/p>

https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2511774<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

Orfoglipron is a novel oral small-molecule that is attracting significant interest from the scientific community because of its potential in research on appetite regulation, weight control and glucose-insulin metabolism.<\/p>","protected":false},"featured_media":34002,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[130,135,15],"product_tag":[137],"class_list":["post-34250","product","type-product","status-publish","has-post-thumbnail","product_cat-produkty-w-kapsulkach-tabletkach","product_cat-produkty-w-kapsulkach","product_cat-laboratory-research","product_tag-kapsulki","first","instock","sale","shipping-taxable","purchasable","product-type-simple"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t